Search Results
Oct 29, 2025, 13:05 ET Independent Petroleum Reserves and Resources Evaluation Identifies 13 Billion Barrel Potential at Jameson Land Basin, Greenland
in Greenland, Finland and Italy, notes the recent announcement as of October 28th, by its US joint venture partner, March GL Company ("March GL") and Pelican (PELI.Nasdaq) ("Pelican"), regarding the results of an independent assessment and prospective resources report prepared by Sproule
More news about: 80 Mile PLC
Oct 29, 2025, 08:55 ET A Supermicro amplia a parceria com a NVIDIA e reforça a conformidade, a integridade dos dados e a qualidade de fabricação de soluções de infraestrutura de IA otimizadas para aplicações governamentais nos EUA.
disponível A Supermicro também está anunciando a disponibilidade geral de sua plataforma de escala de rack ARS-121GL-NB2B-LCC NVL4 para cargas de trabalho científicas de HPC e IA aceleradas por GPU, como simulação molecular, modelagem climática, dinâmica de fluidos
More news about: Super Micro Computer, Inc.
Oct 28, 2025, 14:30 ET Supermicro Expands Collaboration with NVIDIA and Strengthens Compliance, Data Integrity, and Quality of U.S.-Based Manufacturing of AI Infrastructure Solutions Optimized for Government Applications
Accelerated HPC and AI Solution Now Available Supermicro is also announcing general availability of its ARS-121GL-NB2B-LCC NVL4 rack-scale platform for GPU-accelerated HPC and AI science workloads such as molecular simulation, weather modeling, fluid dynamics, and
More news about: Super Micro Computer, Inc.
Oct 28, 2025, 14:30 ET Supermicro Expands Collaboration with NVIDIA and Strengthens Compliance, Data Integrity, and Quality of U.S.-Based Manufacturing of AI Infrastructure Solutions Optimized for Government Applications
Accelerated HPC and AI Solution Now Available Supermicro is also announcing general availability of its ARS-121GL-NB2B-LCC NVL4 rack-scale platform for GPU-accelerated HPC and AI science workloads such as molecular simulation, weather modeling, fluid dynamics, and
More news about: Super Micro Computer, Inc.
Oct 28, 2025, 13:34 ET 80 Mile PLC Secures 3 Strategic MOUs with Fortune 500 Energy Group, Ludoil, and JEnergy and moves to 100% of Ferrandina Biofuels Plant
licenses in East Greenland has positioned the Company in one of the world's most compelling undrilled hydrocarbon basins. Under its agreement with March GL, drilling of two fully funded wells is set to commence, with Pelican Acquisition Corporation's merger with Greenland Exploration valuing 80 Mile's retained
More news about: 80 Mile Plc
Oct 28, 2025, 09:15 ET GL Pools Builds on Family Legacy With Acquisition of Gardiner's Pool Service
About GL Pools Founded in 2006 by Austin Gardiner and Kyle Lobe, GL Pools is a family-owned leader in San Diego's pool service industry, dedicated to excellence, innovation, and personalized care. Our technicians, trained through our proprietary GL University,
More news about: GL Pools
Oct 28, 2025, 09:00 ET Globe Life and North Texas Food Bank Expand Partnership to Deliver Fresh Food Across the Region
Globe Life Inc. (NYSE: GL), a holding company specializing in life and supplemental health insurance, today announced a three-year partnership with
More news about: Globe Life Inc.
Oct 27, 2025, 08:30 ET BioDlink Completes First International Shipment of Bevacizumab to Colombia
With its one-base integrated platform and proprietary technologies—such as BDKcell® for rapid cell line development and GL-DisacLink® for site-specific conjugation—BioDlink helps partners accelerate development, improve efficiency, and reduce costs. The
More news about: BioDlink Biopharm Co., Ltd.
Oct 24, 2025, 04:13 ET 本港首份白皮書揭偏頭痛損害工作效率籲管理層與患者一同正視及治療
2000;40(6):473-479. 2. Peters GL. Am J Manag Care 2019;25:S23-S34. 3.
More news about: 香港頭痛學會
Oct 22, 2025, 16:10 ET GLOBE LIFE INC. REPORTS THIRD QUARTER 2025 RESULTS
MCKINNEY, Texas, Oct. 22, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended September 30, 2025, net income was $4.73 per diluted common share, compared with $3.44 per diluted common share
More news about: Globe Life Inc.
Oct 22, 2025, 08:00 ET Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study
Fraser GL, Lederman S, Waldbaum A, et al. A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant
More news about: Astellas Pharma Inc.
Oct 20, 2025, 10:45 ET Rigid Endoscopes Market worth $2.32 billion by 2030 with 4.9% CAGR | MarketsandMarkets™
actively pursues both organic growth and strategic acquisitions, exemplified by the January 2024 acquisition of Taewoong Medical Ltd., which enhances its GL Endo Therapy portfolio, broadens clinical capabilities, and improves patient care standards. These factors collectively solidify Olympus as a dominant
More news about: MarketsandMarkets
Oct 20, 2025, 08:00 ET RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
Inhibitor Therapy in the United States. ACR Open Rheumatol. 2024 Apr;6(4):179-188. Wei W, Knapp K, Wang L, Chen CI, Craig GL, Ferguson K, Schwartzman S. Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of
More news about: AbbVie
Oct 20, 2025, 07:00 ET Miri Technologies to Unveil New Resilient Internet Platform and Upgrades to X510 Bonding Router at NAB Show New York
miriOS also brings the company's fault-tolerant connectivity to third-party hardware for the first time – starting with the popular GL.iNet Beryl AX (GL-MT3000) travel router. The combination of miriOS with the GL.iNet Beryl AX is ideal for on-the-go internet users who need reliable
More news about: Miri Technologies, Inc.
Oct 14, 2025, 20:00 ET Astellas to Present First Real-World VEOZAH™ (fezolinetant) Data at 2025 Annual Meeting of The Menopause Society
receptor antagonist: a phase 2a trial. J Clin Endocrinol Metab. 2019;104:5893-5905. 4 Fraser GL, Lederman S, Waldbaum A, et al. A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant
More news about: Astellas Pharma Inc.
Oct 09, 2025, 16:10 ET Globe Life Inc. Announces Third Quarter 2025 Earnings Release and Conference Call
MCKINNEY, Texas, Oct. 9, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will announce its Third Quarter 2025 financial results after the market closes on Wednesday, October 22, 2025. At that time, a copy of the Company's
More news about: Globe Life Inc.
Oct 08, 2025, 19:01 ET Global IPO market surges amid rising investor confidence in Q3 2025
https://www.ey.com/en_gl/insights/ipo/trends Notes to Editors
More news about: EYGS LLP
Oct 08, 2025, 19:01 ET Global IPO market surges amid rising investor confidence in Q3 2025
https://www.ey.com/en_gl/insights/ipo/trends Notes to Editors About
More news about: EYGS LLP
Oct 07, 2025, 14:05 ET Ramp Launches Agents for AP to Automate Accounts Payable
Ramp. "This is only possible with agents that can source, understand and apply years of contextual knowledge to make decisions on crucial details like GL codes and approval recommendations." Agentic Workflow Automation for Accounts Payable Agents
More news about: Ramp
Oct 07, 2025, 02:21 ET Beactica conducts first advisory meeting with the Swedish Medical Products Agency regarding the development of BEA-17
several cancer forms, including anti-PD1 checkpoint inhibitors in colon cancer (CT26) and standard of care (temozolomide and radiation) in glioblastoma (GL261). Pharmacokinetic studies of BEA-17 show good blood-brain-barrier penetration and oral availability. BEA-17 is investigational and not approved anywhere
More news about: Beactica Therapeutics AB
Oct 07, 2025, 02:17 ET Beactica conducts first advisory meeting with the Swedish Medical Products Agency regarding the development of BEA-17
several cancer forms, including anti-PD1 checkpoint inhibitors in colon cancer (CT26) and standard of care (temozolomide and radiation) in glioblastoma (GL261). Pharmacokinetic studies of BEA-17 show good blood-brain-barrier penetration and oral availability. BEA-17 is investigational and not approved anywhere
More news about: Beactica Therapeutics AB
Sep 29, 2025, 10:01 ET Printed Electronics Market to Reach US$ 72.4 Billion by 2033 | Astute Analytica
Celsius. In addition, nano3Dprint introduced its DW100-24 Conductive Silver Ink in August 2024, while Creative Materials launched its 125-10ADP and 130-05GL inks in September 2024. Advanced Materials and Next-Generation Substrates Enable New Product Designs
More news about: Astute Analytica
Sep 23, 2025, 03:01 ET Morse Micro Announces Mass Production of MM8108 Wi-Fi HaLow SoC, Modules, Evaluation Kit and HaLowLink 2
Microelectronics's STM32U585 on a FreeRTOS-based IoT platformMM8108-EKH19, integrating Morse Micro's MM8108 SoC on a USB-A dongle with GLi.net's GL-MT3000 router with MediaTek's MT7981B Wi-Fi 6 SoCNow shipping globally through Mouser Electronics, these kits provide developers with a
More news about: Morse Micro
Sep 16, 2025, 09:10 ET LuminUltra Strengthens Position in European Water Diagnostics Market with Strategic Acquisition of GL Biocontrol
GL Biocontrol, a France-based pioneer in microbial testing and risk management for municipal and industrial water systems. Based in Montpellier, GL Biocontrol has been instrumental in advancing
More news about: LuminUltra Technologies Ltd.
Sep 11, 2025, 02:00 ET Pelican Transaction Values 80 Mile's 30% Jameson Interest at US$92M
Definitive Agreement and Plan of Merger with Greenland Exploration Limited ("GEL"), 100% owned subsidiary of March GL Company. GEL has an agreement with March GL Company ("March GL") that will allow it to earn up to 70% in 80 Mile's Jameson liquid hydrocarbon project in Greenland
More news about: 80 Mile PLC